* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
STU:JIL's PEG Ratio is ranked better than 73.28% of 348
companies
in the Drug Manufacturers industry
Industry Median: 1.7
vs STU:JIL: 0.88
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Jilin Province Huinan Changlong Bio-pharmacy Co PEG Ratio Related Terms
Jilin Province Huinan Changlong Bio-pharmacy Co PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co PEG Ratio Chart
Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jilin Province Huinan Changlong Bio-pharmacy Co PEG Ratio vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a PEG Ratio of 0.86 as of Jul. 05, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. This is 48% below median its historical median of 1.64. Over the past decade, Jilin Province Huinan Changlong Bio-pharmacy Co's PEG Ratio has ranged from 0.20 to 3.48. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #93 out of 348 companies in the Drug Manufacturers industry, placing it in the top 26.7%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's PEG Ratio too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current PEG Ratio of 0.86 is 48% below median its 10-year median of 1.64. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 3.48. The Drug Manufacturers industry median PEG Ratio is 1.70. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 0.86 is 49.4% below this industry median. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #93 out of 348 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's PEG Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #93 out of 348 companies for PEG Ratio. This puts Jilin Province Huinan Changlong Bio-pharmacy Co in the upper half of its industry. The industry median PEG Ratio is 1.70. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 0.86 is 49.4% below this benchmark. Historically, Jilin Province Huinan Changlong Bio-pharmacy Co's own PEG Ratio has ranged from 0.20 to 3.48 over the past decade. While the company's 10-year median is 1.64 vs. the industry median of 1.70, Jilin Province Huinan Changlong Bio-pharmacy Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Drug Manufacturers company?
The median PEG Ratio among Drug Manufacturers companies is 1.70, based on 348 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jilin Province Huinan Changlong Bio-pharmacy Co's current PEG Ratio of 0.86 is 49.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median PEG Ratio is 1.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current PEG Ratio is 0.86, which is 48% below median its own 10-year median of 1.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a current PEG Ratio of 0.86. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current PEG Ratio is 0.86, which is 48% below median its 10-year median of 1.64 and 49.4% below the Drug Manufacturers industry median of 1.70. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL), the current PEG Ratio is 0.86 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Overvalued in 2026?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued.
The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.
Key valuation signals for STU:JIL:
PEG Ratio: 0.86 (48% below median its 10-year median of 1.64)
GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
Industry Position: 49.4% below the Drug Manufacturers median (#93 of 348)
No single metric tells the full story. See the STU:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jilin Province Huinan Changlong Bio-pharmacy Co Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score
Get the complete analysis for STU:JIL
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:JIL has been successfully added to your 
